by Darius Koreis
UQ scientists have found MRI’s could be used to predict Alzheimer’s disease. Credit: Tane Sinclair-Taylor
Scientists at the University of Queensland have discovered that magnetic resonance imaging (MRI) could be used to predict the risk of Alzheimer's disease.
The discovery could greatly improve outcomes for Alzheimer's patients, as early diagnosis could increase the effectiveness of drug treatments.
The study, led by Associate Professor Elizabeth Coulson of UQ's Queensland Brain Institute, found that people with a shrinking basal forebrain were seven-times more likely to have worsened cognitive function within 18 months.
"Existing Alzheimer's disease drugs try to enhance the function of the degenerating basal forebrain, but often too much damage is already done by the time drugs are administered," Associate Professor Coulson said.
"Early diagnosis is important for being able to treat people with Alzheimer's disease earlier, and work out a personal treatment course for them.
"If we can give the existing drugs to people earlier, when they first display evidence of a decline in their basal forebrain, even perhaps before they are diagnosed with Alzheimer's disease, then hopefully those drugs will be more effective."
More than 330,000 Australians suffer from Alzheimer's disease and are primarily treated with cholinergic drugs that target the basal forebrain, which degenerates with the condition.
Lead author and QBI PhD student Georg Kerbler said the study used data from the CSIRO's Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing.
They analysed data involving more than 220 elderly people, including 145 healthy people, 40 showing mild cognitive impairment, and 38 with Alzheimer's disease.
"We're now working on validating these findings so a method to assess basal forebrain dysfunction can be rolled out into hospitals in the future," Mr Kerbler said.
"Our MRI method is currently a specialised research tool, and routine diagnosis needs to be performed in hospital MRI departments."
Large clinical trials have found that the effects of cholinergic drugs used to treat Alzheimer's disease are often transient and mild; but some patients appear to benefit from them for many years.
Geriatrician and Prince Charles Hospital Internal Medicine Services Head of Research Dr Eamonn Eeles, said the outcomes of using such drugs could be improved if they were given to patients earlier.
Explore further: New non-invasive method can detect Alzheimer's disease early
More information: Georg M Kerbler, Jürgen Fripp, Christopher C Rowe, Victor L Villemagne, Olivier Salvado, Stephen Rose, Elizabeth J Coulson, Alzheimer's Disease Neuroimaging Initiative, "Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease," NeuroImage: Clinical, Volume 7, 2015, Pages 105-113, ISSN 2213-1582, http://ift.tt/1ALnGtC.
Medical Xpress on facebook
Related Stories
Alzheimer's to be diagnosed online
Jan 08, 2013
(Medical Xpress)—The early onset of Alzheimer's disease could be detected using a simple online test, according to scientists from the Queensland Brain Institute (QBI) at The University of Queensland (UQ). ...
MRI scans gain attention as diagnostic tool for Alzheimer's detection
Feb 11, 2013
(Medical Xpress)—Scientists can now detect early features of Alzheimer's disease using magnetic resonance imaging (MRI) scans.
QBI neuroscientists make Alzheimer's disease advance
Jun 10, 2008
Queensland Brain Institute (QBI) neuroscientists at UQ have discovered a new way to reduce neuronal loss in the brain of a person with Alzheimer's disease. Memory loss in people with Alzheimer's disease can be attributed ...
New non-invasive method can detect Alzheimer's disease early
Dec 22, 2014
No methods currently exist for the early detection of Alzheimer's disease, which affects one out of nine people over the age of 65. Now, an interdisciplinary team of Northwestern University scientists and ...
The relationship between cognitive and functional treatment effects in Alzheimer's patients
Dec 03, 2014
Today, Eli Lilly announced results from new analyses of two Phase 3 trials evaluating the relationship between cognitive and functional treatment effects in patients with mild Alzheimer's disease. Based on post-hoc analyses ...
Recommended for you
Curcumin's ability to fight Alzheimer's studied
49 minutes ago
One of the most promising new treatments for Alzheimer's disease may already be in your kitchen. Curcumin, a natural product found in the spice turmeric, has been used by many Asian cultures for centuries, and a new study ...
A virtual reality brain training game can detect mild cognitive impairment
19 hours ago
Greek researchers demonstrated the potential of a virtual supermarket cognitive training game as a screening tool for patients with mild cognitive impairment (MCI) among a sample of older adults. MCI is a ...
What can beagles teach us about Alzheimer's disease?
Jan 09, 2015
Every 67 seconds someone in the United States is diagnosed with Alzheimer's disease and new estimates suggest that it may be the third leading cause of death of older people. ...
Insulin nasal spray shows promise as treatment for adults with dementia and Alzheimer's
Jan 08, 2015
A man-made form of insulin delivered by nasal spray may improve working memory and other mental capabilities in adults with mild cognitive impairment and Alzheimer's disease dementia, according to a pilot ...
Power of speech could improve dementia diagnosis
Jan 08, 2015
New research from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust found that only half of patients seen at neurology-led memory clinics at the Royal Hallamshire Hospital ...
Patient self-reporting version of 'blood pressure cuff' for dementia is reliable and valid
Dec 29, 2014
The patient self-reporting version of the Healthy Aging Brain Care Monitor—a primary-care tool to measure cognitive, functional and psychological symptoms—is user-friendly, reliable and valid, including being sensitive ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
by Darius Koreis
UQ scientists have found MRI’s could be used to predict Alzheimer’s disease. Credit: Tane Sinclair-Taylor
Scientists at the University of Queensland have discovered that magnetic resonance imaging (MRI) could be used to predict the risk of Alzheimer's disease.
The discovery could greatly improve outcomes for Alzheimer's patients, as early diagnosis could increase the effectiveness of drug treatments.
The study, led by Associate Professor Elizabeth Coulson of UQ's Queensland Brain Institute, found that people with a shrinking basal forebrain were seven-times more likely to have worsened cognitive function within 18 months.
"Existing Alzheimer's disease drugs try to enhance the function of the degenerating basal forebrain, but often too much damage is already done by the time drugs are administered," Associate Professor Coulson said.
"Early diagnosis is important for being able to treat people with Alzheimer's disease earlier, and work out a personal treatment course for them.
"If we can give the existing drugs to people earlier, when they first display evidence of a decline in their basal forebrain, even perhaps before they are diagnosed with Alzheimer's disease, then hopefully those drugs will be more effective."
More than 330,000 Australians suffer from Alzheimer's disease and are primarily treated with cholinergic drugs that target the basal forebrain, which degenerates with the condition.
Lead author and QBI PhD student Georg Kerbler said the study used data from the CSIRO's Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing.
They analysed data involving more than 220 elderly people, including 145 healthy people, 40 showing mild cognitive impairment, and 38 with Alzheimer's disease.
"We're now working on validating these findings so a method to assess basal forebrain dysfunction can be rolled out into hospitals in the future," Mr Kerbler said.
"Our MRI method is currently a specialised research tool, and routine diagnosis needs to be performed in hospital MRI departments."
Large clinical trials have found that the effects of cholinergic drugs used to treat Alzheimer's disease are often transient and mild; but some patients appear to benefit from them for many years.
Geriatrician and Prince Charles Hospital Internal Medicine Services Head of Research Dr Eamonn Eeles, said the outcomes of using such drugs could be improved if they were given to patients earlier.
Explore further: New non-invasive method can detect Alzheimer's disease early
More information: Georg M Kerbler, Jürgen Fripp, Christopher C Rowe, Victor L Villemagne, Olivier Salvado, Stephen Rose, Elizabeth J Coulson, Alzheimer's Disease Neuroimaging Initiative, "Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease," NeuroImage: Clinical, Volume 7, 2015, Pages 105-113, ISSN 2213-1582, http://ift.tt/1ALnGtC.
Medical Xpress on facebook
Related Stories
Alzheimer's to be diagnosed online
Jan 08, 2013
(Medical Xpress)—The early onset of Alzheimer's disease could be detected using a simple online test, according to scientists from the Queensland Brain Institute (QBI) at The University of Queensland (UQ). ...
MRI scans gain attention as diagnostic tool for Alzheimer's detection
Feb 11, 2013
(Medical Xpress)—Scientists can now detect early features of Alzheimer's disease using magnetic resonance imaging (MRI) scans.
QBI neuroscientists make Alzheimer's disease advance
Jun 10, 2008
Queensland Brain Institute (QBI) neuroscientists at UQ have discovered a new way to reduce neuronal loss in the brain of a person with Alzheimer's disease. Memory loss in people with Alzheimer's disease can be attributed ...
New non-invasive method can detect Alzheimer's disease early
Dec 22, 2014
No methods currently exist for the early detection of Alzheimer's disease, which affects one out of nine people over the age of 65. Now, an interdisciplinary team of Northwestern University scientists and ...
The relationship between cognitive and functional treatment effects in Alzheimer's patients
Dec 03, 2014
Today, Eli Lilly announced results from new analyses of two Phase 3 trials evaluating the relationship between cognitive and functional treatment effects in patients with mild Alzheimer's disease. Based on post-hoc analyses ...
Recommended for you
Curcumin's ability to fight Alzheimer's studied
49 minutes ago
One of the most promising new treatments for Alzheimer's disease may already be in your kitchen. Curcumin, a natural product found in the spice turmeric, has been used by many Asian cultures for centuries, and a new study ...
A virtual reality brain training game can detect mild cognitive impairment
19 hours ago
Greek researchers demonstrated the potential of a virtual supermarket cognitive training game as a screening tool for patients with mild cognitive impairment (MCI) among a sample of older adults. MCI is a ...
What can beagles teach us about Alzheimer's disease?
Jan 09, 2015
Every 67 seconds someone in the United States is diagnosed with Alzheimer's disease and new estimates suggest that it may be the third leading cause of death of older people. ...
Insulin nasal spray shows promise as treatment for adults with dementia and Alzheimer's
Jan 08, 2015
A man-made form of insulin delivered by nasal spray may improve working memory and other mental capabilities in adults with mild cognitive impairment and Alzheimer's disease dementia, according to a pilot ...
Power of speech could improve dementia diagnosis
Jan 08, 2015
New research from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust found that only half of patients seen at neurology-led memory clinics at the Royal Hallamshire Hospital ...
Patient self-reporting version of 'blood pressure cuff' for dementia is reliable and valid
Dec 29, 2014
The patient self-reporting version of the Healthy Aging Brain Care Monitor—a primary-care tool to measure cognitive, functional and psychological symptoms—is user-friendly, reliable and valid, including being sensitive ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment